Myocardial Protection Using Del Nido Cardioplegia Solution in Adult Reoperative Aortic Valve Surgery
- 26 May 2014
- journal article
- research article
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 29 (4), 445-449
- https://doi.org/10.1111/jocs.12360
Abstract
Background and Aims The immediate postischemic period is marked by elevated intracellular calcium levels, which can lead to irreversible myocyte injury. Del Nido cardioplegia was developed for use in the pediatric population to address the inability of immature myocardium to tolerate high levels of intracellular calcium following cardiac surgery. Our aim in this study is to determine if this solution can be used safely and effectively in an adult, reoperative population. Methods All patients undergoing isolated reoperative aortic valve replacement at our institution from 2010 to 2012 were retrospectively reviewed. Demographics, comorbidities, operative variables, postoperative complications, and patient outcomes were collected. Patients were divided into two groups based on cardioplegia strategy used: whole blood cardioplegia (WB, n = 61) and del Nido cardioplegia (DN, n = 52). Results Mean age in the study was 73.4 ± 14.3 years and 86 patients were male (76.1%). Eighty‐four patients had undergone prior coronary artery bypass graft (CABG) (74.3%). Patients in the DN group required significantly lower total volume of cardioplegia (1147.6 ± 447.2 mL DN vs. 1985.4 ± 691.1 mL WB, p < 0.001) and retrograde cardioplegia dose (279.3 ± 445.1 mL DN vs. 1341.2 ± 690.8 mL WB, p < 0.001). There were no differences in cross‐clamp time, bypass time, postoperative complication rate, or patient outcomes between groups. Conclusions Del Nido cardioplegia use in an adult, reoperative aortic valve population offers equivalent postoperative outcomes when compared with whole blood cardioplegia. In addition, use of del Nido solution requires lower total and retrograde cardioplegia volumes in order to achieve adequate myocardial protection. doi: 10.1111/jocs.12360 (J Card Surg 2014;29:445–449)This publication has 15 references indexed in Scilit:
- Protecting the aged heart during cardiac surgery: Use of del Nido cardioplegia provides superior functional recovery in isolated heartsThe Journal of Thoracic and Cardiovascular Surgery, 2013
- History and Use of del Nido Cardioplegia Solution at Boston Children’s HospitalThe Journal of ExtraCorporeal Technology, 2012
- Single dose myocardial protection technique utilizing del Nido cardioplegia solution during congenital heart surgery proceduresPerfusion, 2011
- Protecting the aged heart during cardiac surgery: The potential benefits of del Nido cardioplegiaThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Calcium sensitisation impairs diastolic relaxation in post-ischaemic myocardium: implications for the use of Ca(2+) sensitising inotropes after cardiac surgery.European Journal of Cardio-Thoracic Surgery, 2009
- Pediatric Cardioplegia Strategy Results in Enhanced Calcium Metabolism and Lower Serum Troponin TThe Annals of Thoracic Surgery, 2009
- Age-related changes in ischemic tolerance in male and female mouse heartsJournal of Molecular and Cellular Cardiology, 2005
- Prime causes of rapid cardiomyocyte death during reperfusionThe Annals of Thoracic Surgery, 1999
- The Role of the Na+Channel in the Accumulation of Intracellular Na+During Myocardial Ischemia: Consequences for Post-ischemic RecoveryJournal of Molecular and Cellular Cardiology, 1997
- Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest.Circulation, 1976